Hyperfraktionierte akzelerierte Bestrahlung plus Cetuximab plus Cisplatin-Chemotherapie beim lokal fortgeschrittenen, inoperablen Plattenepithelkarzinom im Kopf-Hals-Bereich: 5-Jahres-Ergebnisse einer Phase-II-Studie

Translated title of the contribution: Hyperfractionated accelerated radiation therapy plus cetuximab plus cisplatin chemotherapy in locally advanced inoperable squamous cell carcinoma of the head and neck: Final 5‑year results of a phase II study

Thomas Kuhnt*, Andreas Schreiber, Anett Pirnasch, Matthias G. Hautmann, Peter Hass, Frank P. Sieker, Rita Engenhart-Cabillic, Michael Richter, Kathrin Dellas, Jürgen Dunst

*Corresponding author for this work
4 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Hyperfractionated accelerated radiation therapy plus cetuximab plus cisplatin chemotherapy in locally advanced inoperable squamous cell carcinoma of the head and neck: Final 5‑year results of a phase II study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science